Mike S. Lee Ph.D.President Milestone Development Services
Dr. Lee is the President of Milestone Development Services. He actively participates in the development of new technologies and their integration into industrial settings. Prior to founding Milestone Development Services, Dr. Lee was with Bristol-Myers Squibb. He led interdisciplinary teams responsible for rapid analysis of discovery leads and preclinical drug candidates that contributed to the Food & Drug Administration approval of Buspar?, and Serzone?, and the accelerated development and approval of TAXOL?. Dr. Lee is the founder of the Annual Symposium on Chemical and Pharmaceutical Structure Analysis (CPSA). These unique events, held in the US and China, highlight industry-related applications and discussion on real-world experiences with the latest analytical technology and industry initiatives. Dr. Lee is the author or co-author of over 50 scientific papers and patents. He received his BS degree in Chemistry at the University of Maryland in 1982. In 1985 and 1987, he completed his MS and PhD, respectively, in Analytical Chemistry from the University of Florida under the direction of Professor Richard A. Yost.